/*soh*****************************************************************************************************
 Eli Lilly and Company         -DSS
 LOCATION/NAME                       : J-Review:PRD934/I5Q_MC_CGAS/Concomitant Therapy/CM233 
 PROJECT NAME                        : I5Q
 DESCRIPTION                         : Dose and unit must be consistent compared to the units within the same treatment if present across the study.
 SPECIFICATION LOCATION/NAME         : I5Q-MC-CGAS_mDVP-Report-Specification_v3.0_16AUG2023    
 VALIDATION APPROACH                 : Peer Review 
 SOFTWARE/VERSION#                   : J-Review/Version 11.0.1
 INPUT LOCATION/NAME                 : J-Review/panels/CM233_GS*SQL*
 OUTPUT LOCATION/NAME                : Interactive J-Review Report (view-only)
 STUDY REFERENCE                     : PRD934.I5Q_MC_CGAS 
                                                                         
 SPECIAL INSTRUCTIONS                :  NA
                                                                   
----------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------
 Version History:
 Ver#  Date        Author                  Code History Description
 ----  -------           ---------------         ----------------------------------------------------------
 1.0   20AUG2018   Sruthi Golla         Original Version of the Report
                                                                                     
 *eoh*****************************************************************************************************/
